HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 360, Issue 3, 1999, Pages 295-300

  Wirth, Klaus J ^a   Klaus, Erik ^a   Englert, Heinrich C ^a   Schölkens, Bernward A ^a   Linz, Wolfgang ^a  

^a DG Cardiovascular Diseases   (Germany)

Author keywords

Antiarrhythmic agents; Cardioselectivity; Insulin release; Ischaemia; K(ATP) channel; K(ATP) channel blocker HMR 1883; Rat; Reperfusion; Ventricular arrhythmias; Ventricular fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT; CLAMIKALANT; GLIBENCLAMIDE; GLUCOSE; INSULIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOSELECTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SUDDEN DEATH;

ADENOSINE TRIPHOSPHATE; ADMINISTRATION, ORAL; ANIMALS; ARRHYTHMIA; ARTERIAL OCCLUSIVE DISEASES; BLOOD GLUCOSE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HEART RATE; INJECTIONS, INTRAVENOUS; INSULIN; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; THIOUREA; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0032884859     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900084     Document Type: Article

References (32)

1. ATP channel modulators increase survival rate during coronary occlusion-reperfusion in anesthetized rats. Eur J Pharmacol 324:77-83
2. Ballagi-Pordan G, Koszeghy-Gesztesi A, Koltai MZ, Pogatsa G (1987) Effect of tolbutamide, gliclazide and glipizide on the ventricular ectopic beats and ventricular fibrillation caused by coronary occlusion in rats. Diabetologica 30:496a (Abstr)
3. + channel blocking agent glibenclamide on ischemic and reperfusion arrhythmias. Eur J Pharmacol 326:147-156
4. Billman GE, Avendano CE, Halliwill JR, Burroughs JM (1993) The effects of the ATP-dependent potassium channel antagonist glyburide on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J Cardiovasc Pharmacol 21:197-204
5. Billman GE, Englert HC, Schölkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effect on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 286:1465-1473
6. Bril A, Laville M, Gout B (1992) Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischemia and reperfusion in isolated rat heart. Cardiovasc Res 26:1069-1076
7. Cascio WE, Yan G-X, Kleber AG (1990) Passive electrical properties, mechanical activity, and extracellular potassium in arterially perfused and ischemic rabbit ventricular muscle. Circ Res 66:1461-1473
8. Chi L, Uprichard ACG, Lucchesi BR (1989) Failure of glibenclamide to protect against ventricular fibrillation in a canine model of myocardial infarction. J Mol Cell Cardiol 21:S89 (Abstr)
9. Chi L, Uprichard ACG, Lucchesi BR (1990) Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol 15:452-464
10. Coronel R (1994) Heterogeneity in extracellular potassium concentration during early myocardial ischemia and reperfusion: implications for arrhythmogenesis. Cardiovasc Res 28:770-777
11. D'Alonzo AJ, Darbenzio RB, Parham CS, Grover GJ (1992) Effects of intracoronary cromakalim on postischemic contractile function and action potential duration. Cardiovasc Res 26:1046-1053
12. + channel openers and "natural" cardioprotection. Trends Pharmacol Sci 13:269-272
13. Fosset M, De Weille JR, Green RD, Schmid-Antomarchi H, Lazdunski M (1988) Antidiabetic sulfonylurea control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependenl K+ channels. J Biol Chem 263: 7933-7936
14. Friedrichs GS, Abreu JN, Black SC, Chi L, Lucchesi BR (1996) 5-Hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death. Eur J Pharmacol 306:99-106
15. Gasser RNA, Vaughan-Jones RD (1990) Mechanism of potassium efflux and action potential shortening during ischemia in isolated mammalian cardiac muscle. J Physiol (Lond) 431:713-741
16. Gögelein H, Hartung J, Schölkens BA, Englert HC (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic β-cells. J Pharmacol Exp Ther 286:1453-1464
17. Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223-233
18. Grover GJ (1997) Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 75:309-315
19. Grover GJ, Sleph PG, Dzwonczyk S (1990) Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat heart and anesthetized dogs. J Cardiovasc Pharmacol 16:853-864
20. + loss: a model of ischemia in perfused guinea-pig hearts in vitro. Eur J Pharmacol 220:231-236
21. ATP channel by Glyburide and 5-Hydroxydecanoate. J Biol Chem 273:13578-13582
22. ATP channel blocker HMR 1883 in rabbits. Br J Pharmacol [Proc Suppl] 124:26P (Abstr)
23. Marshall RJ, Muir AW, Winslow E (1981) Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anesthetized rat. Br J Pharmacol 73:951-959
24. Niho T, Notsu T, Ishikawa H (1987) Study of mechanisms and effects of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmias. Folia Pharmacol Jpn 89:155-167
25. + channels in cardiac muscle. Nature 305:147-148
26. Schackow TE, Ten Eick RT (1994) Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by β-adrenoreceptor stimulation. J Physiol (Lond) 474:131-145
27. Toombs CT, Moore TL, Shebuski RJ (1993) Limitation of infaret size in the rabbit by ischemic preconditioning is reversible with glibenclamide. Cardiovasc Res 27:617-622
28. Tosaki A, Engelman RM, Rousou J, Das DK (1992) Aggravation of reperfusion arrhythmias by pinacidil, a potassium channel opener. Circulation 86 [Suppl 1]:1-4
29. Tosaki A, Engelman DT, Engelman RM, Das DK (1995) Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic repefused hearts. J Pharmacol Exp Ther 275:1115-1123
30. + loss and cardiac function in ischemic and reperfused mammalian ventricle. Circ Res 71:1324-1333
31. + channel current in ischemic arrhythmias. Cardiovasc Drugs Ther 7:521-526
32. Wilde AAM, Escande D, Schumacher DA, Thuringer D, Mesure M, Fiolet JWT, Janse MJ (1990) Potassium accumulation in the globally ischemic mammalian heart. Circ Res 67:835-843